Trials / Conditions / Follicular Lymphoma Grade 3A
Follicular Lymphoma Grade 3A
4 registered clinical trials studyying Follicular Lymphoma Grade 3A — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Ly NCT06961500 | Sun Yat-sen University | Phase 2 |
| Recruiting | Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy NCT05377307 | Pell Bio-Med Technology Co., Ltd. | — |
| Recruiting | Phase 1/2 Study of CD19 Chimeric Antigen Receptor T-cell (CD19 CAR-T; PL001) for Relapsed or Refractory B-cell NCT05326243 | Pell Bio-Med Technology Co., Ltd. | Phase 1 / Phase 2 |
| Completed | "MIRO" Molecularly Oriented Immuno-radio-therapy NCT02710643 | Fondazione Italiana Linfomi - ETS | Phase 2 |